Cristina Caffara writes on the substantive implications of the ECJ’s Intel judgment for future cases from an economic perspective, and on the significance and role of the “as-efficient-competitor test” going forward.
Navigating private equity in health care amid regulatory scrutiny
She joined Leslie C. Overton from Axinn Veltrop & Harkrider LLP and Rebekah Goshorn Jurata of the American Investment Council to discuss the growing antitrust...